WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004028541) COMPOSITION FOR THE TREATMENT OF NASOPHARYNGEAL CARCINOMA AND USE THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/028541    International Application No.:    PCT/IB2003/004922
Publication Date: 08.04.2004 International Filing Date: 29.09.2003
Chapter 2 Demand Filed:    24.03.2004    
IPC:
A61K 31/4985 (2006.01), A61K 31/5517 (2006.01)
Applicants: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S. [FR/FR]; 51-53 rue du Docteur Blanche, F-75016 Paris (FR) (For All Designated States Except US).
CENTRE NATIONAL DE RECHERCHE SCIENTIFIQUE [FR/FR]; 3, rue Michel-Ange, F-75794 Paris Cedex 16 (FR) (For All Designated States Except US).
PREVOST, Gregoire [FR/FR]; (FR) (For US Only).
BUSSON, Pierre [FR/FR]; (FR) (For US Only).
VICAT, Jean-Michel [FR/FR]; (FR) (For US Only)
Inventors: PREVOST, Gregoire; (FR).
BUSSON, Pierre; (FR).
VICAT, Jean-Michel; (FR)
Agent: HALL, Robert, L.; Harrison Goddard Foote, Fountain Precinct, Balm Green, Sheffield S1 2JA (GB)
Priority Data:
60/414,103 27.09.2002 US
Title (EN) COMPOSITION FOR THE TREATMENT OF NASOPHARYNGEAL CARCINOMA AND USE THEREOF
(FR) COMPOSITION POUR TRAITER LE CANCER DU NASOPHARYNX ET PROCEDE D'UTILISATION CORRESPONDANT
Abstract: front page image
(EN)Disclosed is a novel drug combination which is useful for the treatment of nasopharyngeal carcinoma, said novel drug combination comprising one or more of a farnesyl transferase inhibitor and one or more of an anthracyline.
(FR)L'invention concerne une nouvelle combinaison de médicaments utilisée pour traiter le cancer du nasopharynx. Cette nouvelle combinaison de médicaments comprend un ou plusieurs inhibiteurs de farnésyl transférase et une ou plusieurs anthracylines.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)